After Hours Summary: BBT boosted by analyst upgrade, IQ / MYOK lower on offering newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to news: INO +5% (initiated with Overweight at Cantor Fitzgerald), X +1.5% (following CNBC FastMoney mention), BBT +1.1% (light volume; upgraded to Buy from Hold at Deutsche Bank), CELG +0.6% (submitted a New Drug Application to the FDA for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis)
After Hours Losers:
Companies trading lower in after hours in reaction to news: IQ -4.5% (proposes offering of $1.05 bln convertible senior notes due 2025), MYOK -3.6% (announces proposed public offering of $200.0 mln of shares of common stock), ALDX -3.4% (schedules call for Tuesday, March 26 at 8 a.m. EDT to provide top-line results from the Phase 3 ALLEVIATE trial of topical ocular reproxalap in patients with allergic conjunctivitis), UTHR -1.1% (light volume; Sandoz announced the US availability of Treprostinil Injection, the first fully substitutable AP rated generic version of Remodulin (treprostinil) Injection, sold by United Therapeutics Corporation)
